Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Indicated for laxity that has progressed beyond what at-home protocols can address
That means you can titrate up from a half dose if you want to see how it affects your performance and potentially save some money by stretching a single bottle out for more than a month
Furthermore, differing definitions of DR may also account for variations in study results
Plant Growth Regul 65(1):101108
Approval (2017) Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation (May 17, 2025) Oral Semaglutide Versus Subcutaneous Liraglutide And Placebo In Type 2 Diabetes (Pioneer 4): A Randomised, Double-Blind, Phase 3a Trial (July 06, 2019) Rybelsus (Accessed September 16, 2025) What to Expect With RYBELSUS (semaglutide) tablets (2024) Find out the cost for RYBELSUS (2024) RYBELSUS (semaglutide) tablets 7 mg or 14 mg Savings Offer | NovoCare (Accessed September 16, 2025) Rybelsus savings and coverage tools for your patients (Accessed September 16, 2025) How Much Does Medicare Drug Coverage Cost